These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6723574)

  • 61. Cleaved prolactin and its 16K fragment are generated by an acid protease.
    Casabiell X; Robertson MC; Friesen HG; Casanueva FF
    Endocrinology; 1989 Oct; 125(4):1967-72. PubMed ID: 2676475
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibition of mammary tumorigenesis by ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomized mice.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1972 Mar; 48(3):715-9. PubMed ID: 5058970
    [No Abstract]   [Full Text] [Related]  

  • 63. Calories, parity, and prolactin influence mammary epithelial kinetics and differentiation and alter mouse mammary tumor risk.
    Engelman RW; Day NK; Good RA
    Cancer Res; 1993 Mar; 53(5):1188-94. PubMed ID: 8382558
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Correlation of rat pituitary prolactin messenger ribonucleic acid and hormone content with serum levels during the estrogen-induced surge.
    Carrillo AJ; Sharp ZD; DePaolo LV
    Endocrinology; 1987 Dec; 121(6):1993-9. PubMed ID: 3678136
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The rat posterior pituitary contains a potent prolactin-releasing factor: studies with perifused anterior pituitary cells.
    Hyde JF; Murai I; Ben-Jonathan N
    Endocrinology; 1987 Oct; 121(4):1531-9. PubMed ID: 2888647
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.
    Vomachka AJ; Pratt SL; Lockefeer JA; Horseman ND
    Oncogene; 2000 Feb; 19(8):1077-84. PubMed ID: 10713693
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prolactin (PRL) processing by kallikrein: production of the 21-23.5K PRL-like molecules and inferences about PRL storage in mature secretory granules.
    Ho TW; Balden E; Chao J; Walker AM
    Endocrinology; 1991 Jul; 129(1):184-92. PubMed ID: 2055182
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Electrophoretically separable forms of rat prolactin with different bioassay and radioimmunoassay activities.
    Asawaroengchai H; Russell SM; Nicoll CS
    Endocrinology; 1978 Feb; 102(2):407-14. PubMed ID: 743965
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mammary tumorigenesis in chemical carcinogen-treated mice. VII. Prolactin and progesterone levels in BALB/c mice.
    Medina D; O'Bryan SB; Warner MR; Sinha YN; VanderLaan WP; McCormack S; Hahn P
    J Natl Cancer Inst; 1977 Jul; 59(1):213-9. PubMed ID: 406413
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of steroids on the size heterogeneity of pituitary prolactin in castrate male rats.
    Haisenleder DJ; Lawson DM; Gala RR
    Life Sci; 1984 Jan; 34(1):31-6. PubMed ID: 6694510
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evidence that autoregulation of prolactin production does not occur at the pituitary level.
    Vician L; Lieberman ME; Gorski J
    Endocrinology; 1982 Mar; 110(3):722-6. PubMed ID: 6895725
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of prolactin secretion by moderate and high doses of testosterone.
    Sinha YN; Gilligan TA; Barkley MS
    Proc Soc Exp Biol Med; 1984 Apr; 175(4):438-43. PubMed ID: 6709643
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Strain-difference in prolactin cells of mouse anterior pituitary between high and low mammary tumor strains by stereological morphometry with an electron microscope.
    Sasaki F; Iwama Y; Sano M
    Okajimas Folia Anat Jpn; 1979 Mar; 55(6):341-50. PubMed ID: 460793
    [No Abstract]   [Full Text] [Related]  

  • 74. Evidence for an influence of mammary tumour virus on prolactin secretion in the mouse.
    Sinha YN; Salocks CB; Vanderlaan WP; Vlahakis G
    J Endocrinol; 1977 Sep; 74(3):383-92. PubMed ID: 200691
    [No Abstract]   [Full Text] [Related]  

  • 75. Ontogenesis of pituitary prolactin in the human fetus.
    Suganuma N; Seo H; Yamamoto N; Kikkawa F; Narita O; Tomoda Y; Matsui N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):156-61. PubMed ID: 2423548
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of nursing on the release of prolactin and GH in mice with high and low incidence of mammary tumors.
    Sinha YN; Salocks CB; Lewis UJ; VanderLaan WP
    Endocrinology; 1974 Oct; 95(4):947-54. PubMed ID: 4472149
    [No Abstract]   [Full Text] [Related]  

  • 77. Cysteamine causes reduction of prolactin monomers followed by aggregation in the rat pituitary gland.
    Scammell JG; Burrage TG; Eisenfeld AJ; Dannies PS
    Endocrinology; 1985 Jun; 116(6):2347-54. PubMed ID: 3996317
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Isolation of two different pools of pituitary prolactin.
    Torres AI; Haggi ES; Aoki A
    Acta Endocrinol (Copenh); 1984 Sep; 107(1):25-30. PubMed ID: 6485703
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Loss of differentiative potential of the mammary gland in ovariectomized mice: prevention and reversibility of the defect.
    Bolander FF; Topper YJ
    Endocrinology; 1980 Nov; 107(5):1281-5. PubMed ID: 6775924
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification and partial characterization of a 25K protein structurally similar to prolactin.
    Sinha YN; Gilligan TA
    Proc Soc Exp Biol Med; 1985 Apr; 178(4):505-14. PubMed ID: 3983129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.